This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease. Infants less than 6 months who have chronic lung disease or other underlying conditions should be given priority, the Centers for Disease Control and Prevention told doctors in a Monday evening, Oct. 23, 2023 alert.
RSV, or respiratory syncytial virus, is a common cause of coldlike symptoms that can be dangerous for young children. A seasonal virus, it's beingThe new, one-time shot is a lab-made antibody that helps the immune system fight off the virus. Sold under the brand name Beyfortus, the drug was developed by AstraZeneca and Sanofi.for infants born just before or during the RSV season and for those less than 8 months old before the season starts.
In a recent letter to state immunization managers, the CDC said there would be a pause on orders for the shots made through a program that pays for vaccines for poor and uninsured children. On Monday, the CDC put out a more general alert to U.S. doctors.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A new shot for RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Source: WOKVNews - 🏆 247. / 63 Read more »
A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Source: wjxt4 - 🏆 246. / 63 Read more »
A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease
Source: KIRO7Seattle - 🏆 271. / 63 Read more »
A new shot for RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease.
Source: WashTimes - 🏆 235. / 63 Read more »
A new RSV shot for infants is in short supplyA new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease. The one-time shot is called Beyfortus. It was developed by AstraZeneca and Sanofi.
Source: AP - 🏆 728. / 51 Read more »
CDC updates RSV shot recommendations due to drug shortagesThe Centers for Disease Control and Prevention issued a health alert Monday in response to limited supplies of an antibody drug designed to protect infants from the respiratory disease RSV.
Source: adndotcom - 🏆 293. / 63 Read more »